| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,346 |
6,919 |
$242K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,209 |
2,681 |
$130K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,644 |
1,376 |
$106K |
| 20610 |
|
2,114 |
1,431 |
$49K |
| 73610 |
|
1,006 |
657 |
$13K |
| 64483 |
|
139 |
101 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
192 |
163 |
$10K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
856 |
740 |
$4K |
| 73630 |
|
226 |
144 |
$3K |
| 73110 |
|
53 |
39 |
$901.17 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
111 |
39 |
$718.59 |
| 73030 |
|
107 |
65 |
$664.43 |
| 73562 |
|
49 |
37 |
$608.75 |
| A4590 |
Special casting material (e.g., fiberglass) |
16 |
12 |
$366.08 |
| 73130 |
|
14 |
12 |
$252.33 |
| 72100 |
|
14 |
13 |
$112.52 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
17 |
13 |
$29.89 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
15 |
15 |
$0.72 |